Abstract:Background and objectives: Epigenetic age estimators indicating faster/slower biological aging vs chronological age independently associate with several age-related outcomes; however, longitudinal associations with cognitive function are understudied. We examined associations of epigenetic age estimators with cognitive function measured annually. Methods: This longitudinal study consisted of older women enrolled in the Women's Health Initiative Memory Study with DNA methylation (DNAm) collected at baseline (1995-1998) from 3 ancillary studies and were followed up to 13 years. Global cognitive function was measured annually by Modified Mini-Mental State Examination (3MS; baseline-2007) and by modified Telephone Interview for Cognitive Status (TICS-m, 2008-2021). We calculated 5 epigenetic age estimators: extrinsic AgeAccel, intrinsic AgeAccel, AgeAccelPheno, AgeAccelGrim2, Dunedin Pace of Aging Calculated From the Epigenome (DunedinPACE), and AgeAccelGrim2 components (DNA-based plasma protein surrogates). We estimated longitudinal epigenetic age estimator-cognitive function associations using linear mixed-effects models containing age, education, race or ethnicity, and subsequently alcohol, smoking, body mass index, and comorbidities. We examined effect modification by APOE ε4 carriage. Results: A total of 795 participants were enrolled. The mean baseline age was 70.8 ± 4 years (10.7% Black, 3.9% Hispanic or Latina, 85.4% White), A 1-SD (0.12) increment in DunedinPACE associated with faster annual declines in TICS-m scores in minimally adjusted (β = -0.118, 95% CI -0.202 to -0.034; p = 0.0006) and fully adjusted (β = -0.123, 95% CI -0.211 to -0.036; p = 0.006) models. AgeAccelPheno associated with faster annual declines in TICS-m with minimal adjustment (β = -0.091, 95% CI -0.176 to -0.006; p = 0.035) but not with full adjustment. No other epigenetic age estimators associated with changes in 3MS or TICS-m. Higher values of DNAm-based surrogates of growth differentiation factor 15, beta-2 microglobulin, Cystatin C, tissue inhibitor metalloproteinase 1, and adrenomedullin associated with faster annual declines in 3MS and TICS-m. Higher DNAm log A1c associated with faster annual declines in TICS-m only. DunedinPACE associated with faster annual declines in 3MS among APOE ε4 carriers but not among noncarriers (p-interaction = 0.020). Discussion: Higher DunedinPACE associated with faster declines in TICS-m and 3MS scores among APOE ε4 carriers. DunedinPACE may help identify older women at risk of future cognitive decline. Limitations include the ancillary studies that collected epigenetic data not designed to study epigenetics and cognitive function. We examined epigenetic age estimators with global cognitive function and not specific cognitive domains. Findings may not generalize to men and more diverse populations.

Accelerated epigenetic age is associated with whole-brain functional connectivity and impaired cognitive performance in older adults

Epigenetic age acceleration as a biomarker for impaired cognitive abilities in adulthood following early life adversity and psychiatric disorders

Epigenetic age acceleration and cognitive performance over time in older adults

DNA methylation age acceleration is associated with incident cognitive impairment in the Health and Retirement Study

Epigenetic age acceleration predicts subject‐specific white matter degeneration in the human brain

Associations of childhood, adolescence, and midlife cognitive function with DNA methylation age acceleration in midlife

Associations of Epigenetic Age Estimators With Cognitive Function Trajectories in the Women's Health Initiative Memory Study

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Accelerated brain aging predicts impulsivity and symptom severity in depression

Abstract P304: Association of Epigenetic Age Acceleration With Cognition in the Bogalusa Heart Study

Association of Epigenetic Age Acceleration with Incident Mild Cognitive Impairment and Dementia among Older Women

Epigenetic Age Acceleration Reflects Long-Term Cardiovascular Health

Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy

Association of Blood‐based Epigenetic Age Acceleration with Cognitive Impairment and Brain Outcomes by Cardiovascular Disease among Women

Connectome-based Predictive Modelling of Ageing, Overall Cognitive Functioning and Memory Performance.

A blood biomarker of accelerated aging in the body associates with worse structural integrity in the brain: replication across three cohorts

Accelerated Global and Local Brain Aging Differentiate Cognitively Impaired from Cognitively Spared Patients with Schizophrenia

Association of a pace of aging epigenetic clock with rate of cognitive decline in the Framingham Heart Study Offspring Cohort

Accelerated DNA methylation age plays a role in the impact of cardiovascular risk factors on the human heart

Brain-predicted age difference is associated with cognitive processing in later-life

Association of DNA methylation age acceleration with digital clock drawing test performance: the Framingham Heart Study